Shares of Safeguard Scientifics, Inc (NYSE:SFE) have been assigned an average broker rating score of 0.00 () from the three brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a hold rating and two have assigned a strong buy rating to the company.
Analysts have set a 1 year consensus price target of $22.00 for the company, according to Zacks. Zacks has also given Safeguard Scientifics an industry rank of 165 out of 265 based on the ratings given to related companies.
Separately, Zacks Investment Research cut shares of Safeguard Scientifics from a “buy” rating to a “hold” rating in a report on Thursday, December 29th.
TRADEMARK VIOLATION NOTICE: “Brokerages Set $22.00 Target Price for Safeguard Scientifics, Inc (SFE)” was reported by Mideast Time and is the sole property of of Mideast Time. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.mideasttime.com/brokerages-set-22-00-target-price-for-safeguard-scientifics-inc-sfe/1589926.html.
Shares of Safeguard Scientifics (NYSE:SFE) opened at 12.20 on Tuesday. Safeguard Scientifics has a 52 week low of $10.60 and a 52 week high of $14.75. The firm’s market cap is $248.44 million. The company has a 50 day moving average of $12.51 and a 200 day moving average of $12.54.
Safeguard Scientifics (NYSE:SFE) last issued its earnings results on Thursday, March 2nd. The company reported ($1.07) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($1.01) by $0.06. During the same period in the prior year, the business earned ($0.69) EPS. On average, equities research analysts anticipate that Safeguard Scientifics will post ($1.35) EPS for the current fiscal year.
Several hedge funds have recently modified their holdings of SFE. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in shares of Safeguard Scientifics during the third quarter worth $159,000. SECOR Capital Advisors LP acquired a new stake in shares of Safeguard Scientifics during the third quarter worth $220,000. Russell Investments Group Ltd. acquired a new stake in shares of Safeguard Scientifics during the fourth quarter worth $261,000. Perritt Capital Management Inc. acquired a new stake in shares of Safeguard Scientifics during the fourth quarter worth $319,000. Finally, DnB Asset Management AS boosted its stake in shares of Safeguard Scientifics by 2.2% in the third quarter. DnB Asset Management AS now owns 28,158 shares of the company’s stock worth $365,000 after buying an additional 600 shares during the period. 77.30% of the stock is currently owned by institutional investors.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc and related companies with MarketBeat.com's FREE daily email newsletter.